Search - tctmd.com

Displaying 721 - 740 of 948

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Urgent Transcatheter Aortic Valve Replacement for Severe Acute Aortic Regurgitation Following Open Mitral Valve Surgery

Presenter: Ashish Pershad, Roberto Spina, MD

June 21, 2018

Presentation SCAI 2018

Derivation of a Simple Risk Tool to Predict 30-day Readmissions after Transcatheter Aortic Valve Replacement

Presenter: Sahil Khera

April 28, 2018

Presentation SCAI 2018

3D Printing and Computer Modeling to Predict Paravalvular Leak in Transcatheter Aortic Valve Replacement

Presenter: Sergey Gurevich

April 28, 2018

Presentation CRT 2018

Transcatheter Aortic Valve Replacement for Patients with Severe Aortic Stenosis who are at Low Risk For Mortality: Interim results from the Prospective Multicenter LRT Clinical Trial

Presenter: Ron Waksman

March 04, 2018

Presentation TCT 2017

30-Day Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Valve Disease Secondary to Mitral Annular Calcification or Failed Annuloplasty Rings

Presenter: Mayra Guerrero

November 01, 2017

Presentation TCT 2017

TCT 107: Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: Complete 1-Year Outcomes From the SURTAVI Trial

Presenter: Steven R. Bailey, Patrick W. Serruys, Nicolas M. Van Mieghem

November 01, 2017

Presentation TCT 2017

Aortic Valve Replacement for CHF

Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Howard C. Herrmann

October 31, 2017

Presentation TCT 2017

Case #2: Double Aortic and Mitral Transcatheter Valve Replacement Using Innovative Bioprostheses

Presenter: João AB Brum Silveira, Marcelo Jose de Carvalho Cantarelli, Henrique B. Ribeiro

October 31, 2017

Presentation TCT 2017

TCT 30: Instantaneous Wave-Free Period Variations after Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis

Presenter: Justin E. Davies, Bernard De Bruyne, Gabriele Pesarini, MD

October 31, 2017

Presentation TCT 2017

TCT 36: Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement

Presenter: Reginald I. Low, Michael J. Rinaldi, Richard Jabbour

October 31, 2017

Presentation TCT 2017

TCT 52: Novel Preclinical Assessment of Transcatheter Mitral Valve Replacement by Micro-Computed Tomography: µCT Imaging-Guided Histopathological Evaluation

Presenter: Peter C. Block, Lars Sondergaard, Armando Tellez, MD

October 31, 2017

Presentation TCT 2017

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

Presenter: Reginald I. Low, Michael J. Rinaldi, Julia Seeger

October 31, 2017

Presentation TCT 2017

TCT 91: Antithrombotic Therapy Post Transcatheter Aortic Valve Replacement in Patients With No Indication for Anticoagulation

Presenter: Kurt Huber, Jamil Abdalla Saad, Dimitrios Alexopoulos, Antonio L. Bartorelli, Bjorn Redfors, Carlos E. Uribe

October 31, 2017

Presentation TCT 2017

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

Presenter: Peter C. Block, Lars Sondergaard, Tarun Chakravarty, MD

October 31, 2017

Presentation TCT 2017

TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement

Presenter: Peter C. Block, Lars Sondergaard, Maria Del Trigo, MD

October 31, 2017

Presentation TCT 2017

TCT 49: Long-Term Valve Function 5-9 Years After Transcatheter Aortic Valve Implantation: Data From the UK-TAVI Registry. On Behalf of the National Institute for Cardiovascular Outcomes Research (NICOR)

Presenter: Peter C. Block, Lars Sondergaard, Daniel J. Blackman

October 31, 2017

Presentation TCT 2017

Featured Lecture: Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients : Complete 1-Year Outcomes from the SURTAVI Trial

Presenter: Martin B. Leon, Patrick T. O'Gara, Nicolas M. Van Mieghem

October 30, 2017

Presentation TCT 2017

Featured Lecture: The Vancouver Multidisciplinary, Multimodality, but Minimalist Clinical Pathway Facilitates Safe Next Day Discharge Home at Low, Medium, and High Volume Transcatheter Aortic Valve Replacement Centres: the 3M TAVR Study

Presenter: Robert O. Bonow, Michael J. Mack, David A. Wood

October 30, 2017

Presentation TCT 2017

Germany Presents: Future Perspective - TAVR Compared to Surgical Valve Replacement in Patients With Low-Risk Scores Potential Benefits and Harms

Presenter: Dariusz Dudek, Martin Hudec, Michael Haude

October 30, 2017

Presentation TCT 2017

Transcatheter Aortic Valve Replacement With the HLT Meridian® Valve: Initial Clinical Experience

Presenter: Nicolo Piazza, Josep Rodés-Cabau

October 30, 2017

Advertisement

Urgent Transcatheter Aortic Valve Replacement for Severe Acute Aortic Regurgitation Following Open Mitral Valve Surgery

Derivation of a Simple Risk Tool to Predict 30-day Readmissions after Transcatheter Aortic Valve Replacement

3D Printing and Computer Modeling to Predict Paravalvular Leak in Transcatheter Aortic Valve Replacement

Transcatheter Aortic Valve Replacement for Patients with Severe Aortic Stenosis who are at Low Risk For Mortality: Interim results from the Prospective Multicenter LRT Clinical Trial

30-Day Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Valve Disease Secondary to Mitral Annular Calcification or Failed Annuloplasty Rings

TCT 107: Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: Complete 1-Year Outcomes From the SURTAVI Trial

Aortic Valve Replacement for CHF

Case #2: Double Aortic and Mitral Transcatheter Valve Replacement Using Innovative Bioprostheses

TCT 30: Instantaneous Wave-Free Period Variations after Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis

TCT 36: Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement

TCT 52: Novel Preclinical Assessment of Transcatheter Mitral Valve Replacement by Micro-Computed Tomography: µCT Imaging-Guided Histopathological Evaluation

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

TCT 91: Antithrombotic Therapy Post Transcatheter Aortic Valve Replacement in Patients With No Indication for Anticoagulation

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement

TCT 49: Long-Term Valve Function 5-9 Years After Transcatheter Aortic Valve Implantation: Data From the UK-TAVI Registry. On Behalf of the National Institute for Cardiovascular Outcomes Research (NICOR)

Featured Lecture: Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients : Complete 1-Year Outcomes from the SURTAVI Trial

Featured Lecture: The Vancouver Multidisciplinary, Multimodality, but Minimalist Clinical Pathway Facilitates Safe Next Day Discharge Home at Low, Medium, and High Volume Transcatheter Aortic Valve Replacement Centres: the 3M TAVR Study

Germany Presents: Future Perspective - TAVR Compared to Surgical Valve Replacement in Patients With Low-Risk Scores Potential Benefits and Harms

Transcatheter Aortic Valve Replacement With the HLT Meridian® Valve: Initial Clinical Experience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content